All Employment articles – Page 3
-
BusinessRussia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
-
BusinessAlexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
-
BusinessEli Lilly to cut 3500 jobs
Company will close sites in US and China, and provide incentives for early retirement
-
BusinessIsraeli company Haifa Chemicals shuttered
Lack of ammonia storage facility leads to colossal losses
-
BusinessMidwest Fertilizer to build $2.8bn manufacturing plant
Domestic facility will reduce imports
-
BusinessLyondellBasell to build world’s largest propylene oxide plant
Petrochemical giant gets go-ahead for most expensive project to date
-
NewsSpain loses 12,000 researchers in five years
Falling R&D investment is leading to a ‘brain drain’
-
BusinessHow do chemical firms last hundreds of years?
What distinguishes companies that thrive from others that failed?
-
BusinessJob cuts at Amgen, Takeda and Vertex
Takeda reorganising following Ariad takeover, while Amgen and Vertex move staff to Cambridge and San Francisco hubs
-
BusinessJ&J to close Scottish medical device plant
Up to 400 positions affected as Ethicon subsidiary leaves Livingston
-
BusinessDaiichi Sankyo to close R&D sites in India and Japan
Closures are part of an ongoing reorganisation aimed at increasing productivity
-
BusinessUS biotech leaders protest immigration ban
Donald Trump’s suspended order would endanger America’s biotech industry if re-instated
-
OpinionHow much is your chief executive worth?
The executive pay and equality debate is here to stay
-
BusinessLilly buys CoLucid for migraine drugs
US firm also laying off 485 sales staff after Alzheimer’s drug failure
-
BusinessMosaic to buy Vale Fertilizantes in $2.5bn deal
Fertiliser deal continues consolidation trend and expands Mosaic’s presence in Brazil
-
-
BusinessBristol-Myers Squibb planning huge reorganisation in the US
Job losses likely as Hopewell, New Jersey site will close by 2020
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
BusinessEndo drops opioid painkiller rights and cuts US sales force
375 staff to go as Endo says its established pain drugs ‘no longer require field promotion’
-
BusinessBoehringer Ingelheim sheds more jobs in the US
Over 240 staff to go as company refocuses on immuno-oncology